PEG-interferon α-2b plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon A or interferon α-2b plus ribavirin therapy.

被引：0
|
作者：
Sulkowski, M
Rothstein, KD
Stein, L
Godofsky, E
Shoultz, D
Hudnall, R
Huff, M
Dieterich, D
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] PPD Dev, Seattle, WA USA
[5] Hepatitis Resource Network, Tacoma, WA USA
[6] NYU, Sch Med, New York, NY USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
987
引用
下载
收藏
页码：419A / 419A
页数：1
相关论文
共 50 条
  • [1] PEG-Interferon α-2b+ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon alfa or interferon a-2b+ribavirin therapy.
    Sulkowski, M
    Rothstein, K
    Stein, L
    Godofsky, E
    Goodman, R
    Dieterich, D
    GASTROENTEROLOGY, 2003, 124 (04) : A783 - A783
  • [2] Alfa interferon 2b and Ribavirin for treatment of patients with chronic hepatitis C who have failed alpha interferon 2b as single therapy.
    Blanchard, D
    Reed, T
    Freeman, S
    Weiner, K
    Bader, T
    HEPATOLOGY, 1998, 28 (04) : 284A - 284A
  • [3] Response to interferon alpha 2B plus ribavirin in hepatitis C infected patients who failed interferon alpha 2B monotherapy.
    King, JW
    Favrot, DR
    Shakhashiro, A
    Gholson, CF
    Balart, LA
    Achord, J
    Kirkikis, JA
    Lyles, WE
    Hollier, JD
    Srinivas, D
    HEPATOLOGY, 1998, 28 (04) : 708A - 708A
  • [4] Interleukin-2 plus ribavirin versus interferon-α-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-α-2b treatment
    Malaguarnera, M
    Pistone, G
    Neri, S
    Romano, M
    Brogna, A
    Musumeci, S
    BIODRUGS, 2004, 18 (06) : 407 - 413
  • [5] Interleukin-2 Plus Ribavirin Versus Interferon-α-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-α-2b Treatment
    Mariano Malaguarnera
    Giovanni Pistone
    Sergio Neri
    Marcello Romano
    Alfio Brogna
    Salvatore Musumeci
    BioDrugs, 2004, 18 : 407 - 413
  • [6] Interferon-β induction/interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, KI
    Sasase, N
    Taniguchi, M
    Mita, K
    Kinoshita, K
    Togitani, T
    Shikata, M
    Kimura, N
    Izawa, S
    Ohtani, A
    Nakao, K
    Muramoto, Y
    Kim, SR
    Nabeshima, S
    Ishii, F
    Tanaka, K
    Hayashi, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (02) : 71 - 76
  • [7] Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
    Siebert, U
    Sroczynski, G
    Rossol, S
    Wasem, J
    Ravens-Sieberer, U
    Kurth, BM
    Manns, MP
    McHutchison, JG
    Wong, JB
    GUT, 2003, 52 (03) : 425 - 432
  • [8] Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    Mosaburo Kainuma
    Norihiro Furusyo
    Eiji Kajiwara
    Kazuhiro Takahashi
    Hideyuki Nomura
    Yuichi Tanabe
    Takeaki Satoh
    Toshihiro Maruyama
    Makoto Nakamuta
    Kazuhiro Kotoh
    Koichi Azuma
    Junya Shimono
    Shinji Shimoda
    Jun Hayashi
    World Journal of Gastroenterology, 2010, 16 (35) : 4400 - 4409
  • [9] Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    Kainuma, Mosaburo
    Furusyo, Norihiro
    Kajiwara, Eiji
    Takahashi, Kazuhiro
    Nomura, Hideyuki
    Tanabe, Yuichi
    Satoh, Takeaki
    Maruyama, Toshihiro
    Nakamuta, Makoto
    Kotoh, Kazuhiro
    Azuma, Koichi
    Shimono, Junya
    Shimoda, Shinji
    Hayashi, Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (35) : 4400 - 4409
  • [10] Efficacy of PEG-interferon α-2B (PEG-IFN) plus ribavirin in responder-relapsers to a previous course of interferon α plus ribavirin
    Basso, M
    Torre, E
    Grasso, A
    Percario, GF
    Azzola, E
    Artioli, S
    Pelli, N
    Picciotto, A
    JOURNAL OF HEPATOLOGY, 2005, 42 : 199 - 199
12345